This hearing examines China’s efforts to improve its national healthcare system and the implications for the United States. It will look at China’s recent efforts to meet the basic healthcare needs of its citizens, who in many cases remain severely underserved by China’s healthcare system. It will discuss how China seeks to use digital healthcare to both address basic systemic deficiencies and develop cutting-edge solutions to emerging healthcare problems. The hearing will also address the role that access to healthcare data—including U.S. healthcare data—plays in China’s development plans, and the extent to which U.S. firms and researchers enjoy reciprocal access to China’s healthcare data.
This virtual public roundtable discussion “A ‘China Model?’ Beijing’s Promotion of Alternative Global Norms and Standards” assesses the intentions behind China’s efforts to revise international governance institutions, norms, and values. It examines Beijing’s vision for a revised global order, attempts to identify whether a distinguishable “China model” exists, and assesses the extent to which Beijing is seeking to export such a model to other countries.
A public hearing on “A ‘China Model?’ Beijing’s Promotion of Alternative Global Norms and Standards” was unable to be held on the originally scheduled date, March 13, 2020, due to the Sergeant at Arms' decision to temporarily limit access to the Capitol Complex. Witness testimony has since been accepted and posted below. Questions for the record solicited by the Commission will be similarly be posted below once available.
This hearing will examine China’s ability to project military power and influence beyond its shores, with an emphasis on the country’s development of expeditionary capabilities. An official from the U.S. Department of Defense will provide testimony on how the Administration views China’s power projection and how such capabilities further China’s plans to reorder the Indo-Pacific and other key regions to its advantage. The first panel of experts will explore why and how China is developing expeditionary capabilities, with a focus on the Belt and Road Initiative (BRI) as a vehicle for testing and justifying these capabilities. The second panel will focus on the ‘‘nuts and bolts’’ of China’s expeditionary capabilities, including the PLA’s efforts to improve its logistics organization and expand its access to overseas bases. The third panel will examine how China’s activities in South and Southeast Asia, Africa, and Latin America and the Caribbean further its development of expeditionary capabilities.
The U.S.-China Economic and Security Review Commission’s first hearing in 2020 examines the internal dynamics of China’s financial system; China’s increasingly rapid integration into global financial markets; and the risks this poses to U.S. investors and savers. The first Panel examines China’s overall capital requirements and systemic challenges to raising new capital. The second panel identifies and evaluates methods different actors in the Chinese economy use to raise capital and access financing. The third panel is designed to assess the exposure of U.S. investors to the growing integration of Chinese securities into global capital markets, with a particular emphasis on index inclusions and Chinese companies’ engagement with U.S. equities markets.
The hearing will review key developments in the U.S.-China relationship in 2019. Panel 1 will evaluate developments in China’s political economy and the impact of U.S.-China trade frictions on the Chinese economy. Panel 2 will assess the implications of Chinese military activities and modernization in 2019 for the United States and U.S. allies and partners. Panel 3 will review the implications of economic, political, and security developments between China and Taiwan for regional security, and explore the escalating situation in Hong Kong.
The hearing will assess China’s role in global health, pharmaceuticals, and medical products. In addition, it will examine the activities of Chinese health and biotech firms in the United States, and U.S. access to China’s health market. Finally, the hearing will consider the implications for U.S. public health and national security of growing U.S. dependence on Chinese health products.
In his report to the 19th Congress of the Chinese Communist Party, General Secretary Xi Jinping declared that China would complete the modernization of its armed forces by 2035 and transform them into “world-class forces” by the middle of the 21st century. Xi’s vision for the composition and mix of capabilities that would allow the People’s Liberation Army to be judged to be a “world-class” military is unknown. Will it be a force with global expeditionary capability, mimicking the United States, or an overwhelming regional force reminiscent of Imperial Japan in 1941? Or, as the two are not necessarily mutually exclusive, could it be both? This hearing will explore what the implications of a world-class Chinese military might be for the United States and its allies and partners, with the goal to begin a public dialogue on this topic and develop recommendations for Congress on how the United States might best protect its interests in the face of a highly-capable Chinese competitor.
Technology, Trade, and Military-Civil Fusion: China’s Pursuit of Artificial Intelligence, New Materials, and New Energy
This hearing will examine China’s development of artificial intelligence, new materials, and energy storage, renewable energy, and nuclear power. It will assess China’s capabilities in producing and commercializing these technologies vis-à-vis the United States and its ambitions to export these technologies and shape their global governance in ways that disadvantage the United States. The hearing will also consider China’s potential military application of these technologies and strategic implications for the United States.
This hearing will examine the implications for the United States of a commercial, scientific, diplomatic, and military strategic competition with China. The hearing will begin with two individual panels comprising a strategic planning perspective on competition with China in space and a current Administration official’s assessment of the balance of power in space and China’s current space-based surveillance capabilities, respectively. The first full panel will examine China’s pursuit of global space leadership, focusing on China’s international space partnerships, its views on international law in space, and its exploration ambitions. The second panel will address the role of military-civil fusion in China’s space ambitions, including the role of military-civil fusion in context of China’s national space goals, U.S. competition with Chinese companies in the international satellite industry, and the adequacy of U.S. export controls. Finally, the third panel will examine China’s military space activities, focusing on its national military space goals and doctrine, its military space and counterspace capabilities, and the intersection of cyber and space in China’s strategy and operations.